Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide EBA Study in TB
NCT02684240Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Feb 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in Tuberculosis (TB), sponsored by Weill Cornell Medicine. Started Feb 2016; status: completed.
02
Drugs
nitazoxanide
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02684240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684240.